Citi Pharma Limited
↗Lahore, Punjab, Pakistan
Citi Pharma Limited is a Pakistan-based pharmaceutical company incorporated on October 8, 2012, that manufactures and distributes active pharmaceutical ingredients (APIs), finished dosage forms, and botanical products. The company acquired the operations of Askari Pharmaceuticals Private Limited from Army Welfare Trust in 2013 and has maintained a track record of excellence for over 38 years as an API and manufacturing partner. Citi Pharma supplies pharmaceuticals to major international companies including GlaxoSmithKline and Abbott. The company operates production facilities in Kasur with formulation, API, and R&D departments, producing a comprehensive portfolio of therapeutic agents.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Active Pharmaceutical Ingredients (API) & Finished Dosage Forms
SIZE & FINANCIALS
Employees:101-500
Revenue:$5M-$10M (13.15 billion PKR in 2025)
Founded:2012
Ownership:public
Status:operating
FUNDING
Stage:Public Company
Total Raised:Rs 2.33 billion (2021 IPO)
Investors:Multiple institutional and retail investors from 2021 IPO
STOCK
Exchange:PSX
Ticker:CPHL
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial products
Modalities:Small molecule, API, Tablets, Liquids, Capsules, Nutraceuticals
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Xin Weisheng (China) - Advanced antibiotic manufacturing facility partnership, commercial production expected 2026, Murli Krishna Pharma (India) - Supply agreement for pharmaceutical products (2024), GlaxoSmithKline - Major customer/supplier relationship, Abbott - Major customer/supplier relationship
COMPETITION
Position:Emerging Leader
Competitors:Abbott Laboratories (Pakistan), GlaxoSmithKline Pakistan, Searle Pakistan, Pfizer Pakistan, Bayer Pakistan, AstraZeneca Pakistan
LEADERSHIP
Key Executives:
Rizwan Ahmad - Chief Executive Officer
Nadeem Amjed - Chairperson and Director
Dr. Zamir Ul Hassan - Managing Director
Shahzad Ahmed - Corporate Head / Head of International Trade
Amir Zia - Finance Director
Board Members:Nadeem Amjed, Dr. Zamir Ul Hassan
LINKS
Website:citipharma.com.pk
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Citi Pharma Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Citi Pharma Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.